Multiscale computational models of heart are being extensively investigated for improved assessment of drug-induced Torsades de Pointes (TdP) risk, a fatal side effect of many drugs. Model-derived metrics (features) such as action potential duration, net charge carried by ionic currents (qN et) and others have been proposed in the past as potential candidates for classifying TdP risk. However, the criteria for selection of new risk metrics are still poorly justified, and they are often trained/tested only on small datasets. Moreover, classifiers built on derived features have thus far not consistently provided increased prediction accuracies compared to classifiers based on in vitro measurements of drug effects on ion channels (direct features). In this paper, we analyze a large population of virtual drugs to examine systematically the sensitivity of several model-derived features. The influence of different ion channels in regulation of the model-derived features is identified using global sensitivity analysis (GSA). Specifically, the analysis points to key differences in the input parameters that affect several model-derived features and the generation of early afterdepolarizations (EAD), thus opposing the idea that these features and sensitivity to EAD might be strongly correlated. We also demonstrate that previously proposed model-derived features could be well fitted by a linear combination of direct features. This well explains the observed comparable performances of classifiers built on direct features and model-derived features. Combining GSA and simple probability analysis, we also show that the odds of any linear metric constructed from direct features to perform as well as qN et is very low. Nevertheless, despite high predictive power of qN et to separate drugs into correct categories of TdP risk, the GSA results suggest that the actual mechanistic interpretation for qN et s improved performance deserves further investigation. In conclusion, analyses like ours can provide more robust feature selection/construction. Improved experimental designs with increased focus on the critical model parameters indicated by GSA can potentially reduce the uncertainties of key model components and result in increased confidence of TdP risk predicted by in silico models.
Introduction
Ventricular myocyte models of rabbit, rat and human 31 [6] C drug,EAD EF T P C Human ventricular myocyte model 31 from [6] [7] T DR Human ventricular myocyte model 55 from [16] [8]
C Drug,Arrhythmia EF T P C 3D FEM model of human heart 12 [17] AP D 50 &DiastolicCa 2+ Human ventricular myocyte model 86 from [6, 16] [9] cqInward Human ventricular myocyte model 12 [10] T dP population,score Human ventricular myocyte model 62 (55 from [16] ) [18] 
qN et
Human ventricular myocyte model 12 [11] C drug,EAD -concentration of the drug that produces EAD. C drug,Arrhythmia -concentration of the drug that produces arrhythmia in the model, T DR -Transmural dispersion, cqInward -metric that that quantifies the change in the amount of charge carried by INaL and ICaL, AP D90 -Action potential duration at 90% amplitude, AP D50 -Action potential duration at 50% amplitude, DiastolicCa 2+ -Diastolic calcium concentration and T dP population,score -The fraction of models developing repolarization abnormalities(RA) multiplied by a factor inversely related to the drug concentration at which those RA occur Methods 39 To perform GSA, we generated a large set of virtual drugs. A virtual drug comprises a random vector of changes to 40 parameters of ion channels of the model. Responses to the virtual drugs were examined through evaluation of several 41 model-derived features such as AP D 90 , qN et, and peak calcium concentration (peakCa). The CiPAORd model and 42 input parameters section describes the in silico model used in the paper. The details of the input parameters considered 43 for generating the virtual drug population are presented in Sampling virtual drug population. The section In silico 44 simulations and derived features presents details on the derived features extracted from the in silico models. The virtual 45 drugs were also tested for their ability to induce EAD in the model. In the section EAD protocols we describe the 46 protocols used to test for EAD generation in the model. The methods used for GSA are described in the Global 47 sensitivity analysis. The methods used for classifying virtual drugs based on direct and derived features with respect to 48 EAD are listed in Binary risk stratification of virtual drug population. Finally, we describe the methods for classifying 49 the 28 drugs selected under the CiPA initiative, which we refer in the manuscript as "CiPA drugs", with respect to their 50 defined torsadogenic risk in the section Tertiary risk stratification of "CiPA drugs". 51 CiPAORd model and input parameters 52 In this study, we perform GSA on the CiPAORd model [11] . The CiPAORd model was developed at FDA by introducing 53 several modifications to the original O'Hara-Rudy ventricular myocyte model [19] to improve proarrhythmic risk 54 assessment. 55 Several input parameters have been used for simulation of drug effects. For the hERG channels, we used the 56 concentration response of the drug, E max , the unbinding reaction rate, K u , and the membrane voltage at which half of 57 
where current = {IN a, IN aL, ICaL, IKs, IK1, Ito}, IC 50,current is the drug concentration at which a current is 63 4/48 reduced by half, C drug is the drug concentration, and h is the Hill coefficient. The drug-induced blocks of channel currents 64 b current,drug are used to scale the maximum conductance of the current g current in the in silico model calculated as 65 g current,drug = 100% − b current,drug 100% × g current .
We perform GSA explicitly with respect to b current,drug rather than IC 50,current , C drug , and h. In this study, we refer to 66 the parameters of the block of IN a, IN aL, ICaL, IKs, IK1 and Ito as bIN a, bIN aL, bICaL, bIKs, bIK1, and bIto, 67 respectively. Equation (1) is used in classification of real compounds. 68 Sampling virtual drug population 69 The population of virtual drugs is created through Monte Carlo sampling from a high-dimensional (10-D) input 70 parametric space. The parametric space represent changes in model parameters used to describe drug binding and blocks 71 of ionic currents. Basic cycle length (BCL) of cell pacing in the simulations was also considered as a parameter for GSA. 72
The input parameters and their examined ranges is provided in ( Table 2 ). In some cases, GSA was performed on metrics derived from outputs of a mid-myocardial cell (defined as M cell in [19] ) model. M cells are very sensitive to blocks of 74 repolarization currents and produce EAD more easily. Sensitivity to EADs makes the analysis more complicated, and the 75 range of hERG block for M cells had to be accordingly reduced. 76 In silico simulations and derived features 77 The action potential and calcium transients of the cells were simulated for the large virtual population of drug dataset 78 (>10000 drugs) generated for GSA, and, separately, for the CiPA training (12 drugs) and validation (16 drugs) datasets 79 (manual patch clamp data) [10, 11] using the CiPAORd model. Model simulations were run for 200 beats to achieve 80 steady state. Simulations were carried out at different pacing rates (a parameter in GSA) for each of the endocardial 81 (endo), mid-myocardial (M), and epicardial (epi) cell types. Several standard metrics explored previously for TdP risk 82 discrimination were calculated from the action potential and Ca 2+ transients. The metrics obtained from the in silico 83 models are listed in the Table 3 . Note that the metric qN et was calculated as the area under the curve traced by the net 84 current (Inet = ICaL + IN aL + IKr + IKs + IK1 + Ito) from the beginning to the end of the last simulated beat as 85 defined in [11] . 86 model was more prone to EAD generation than the endo cell type. We tested generation of pause-induced EADs (that 90 are implicated as triggers of TdP [20] [21] [22] ) in the M cell type as in our previous study [14] . Briefly, the cell was stimulated 91
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200 times at a constant cycle length. After 200 stimuli, an additional stimulus was applied following a pause equal to the 92 basic cycle length. In the endo cells, pause-induced EADs occurred rarely, and we examined drug-induced EAD risk in 93 presence of an added perturbation by reducing the maximum conductance of hERG channel current (IKr) as in [11] .
94
The cell was stimulated for 200 beats with additional block of maximum conductance of IKr by 85%. The 85% block was 95 selected since almost half of the population of virtual drugs (across the entire parametric space observed) resulted in EAD 96 development in the model simulations.
97
Global sensitivity analysis 98 GSA was performed using a difference-based Morris sensitivity method [23] , a variance-based sensitivity method [24, 25] ), 99
and Monte Carlo filtering [24, 26] . 100 Morris method
101
The Morris-method [23] provides the simplest form of GSA and can be considered as an extension of the local sensitivity 102 methods. Similar to other local sensitivity analysis methods, the input parameters are varied one at a time (OAT) to 103 obtain the partial derivatives of output metrics with respect to individual input parameters. A k-dimensional unit cube 104 (representing k independent normalized input parameters) is discretized into the p-level grid Ω. Unlike for local sensitivity 105 analysis, however, the reference values of each parameter are selected randomly from the set {0, 1/(p-1), 2/(p-1) ... , 1 -106 ∆} rather than perturbing some nominal values. The fixed increment ∆ = p/2(p − 1) is added to each parameter one at a 107 time in a random order to compute the elementary effect (EE) of the i th input parameter X i , parameters based on their influence [24] and σ EE helps identify nonlinear and/or interaction effects. The Python SALib 113 package was used to perform the elementary effect analysis [27] . In this study, we considered r = 1000 unless otherwise 114 specified, resulting in 9000 and 11000 input samples (virtual drugs) for k = 8 and 10, respectively.
115
Variance-based global sensitivity analysis 116 Sobol sensitivity analysis method [25] is a model-independent GSA method that is based on variance decomposition. It 117 relies on an all-at-time (AAT) sampling strategy where output variations are induced by varying all the input factors 118 simultaneously. Let a derived-metric Y from a computational model be represented by a function f of the input 119 parameters,
where X = {X 1 , X 2 · · · X k } is the input parameter set. The function can then be decomposed into a sum of elementary 121 functions of increasing dimensions,
The input parameters are assumed to be random variables that uncorrelated and mutually independent. The functional 123 decomposition can be translated into a variance decomposition. This allows to quantify the variance contribution to the 124 total output of individual parameters and the parameter interactions,
where
and so on are the higher-order effects due to 127 interactions of model inputs. Here, E Xi , V Xi are expectation and variance taken over X i ; X ∼i denotes all factors but X i . 128
The Sobol sensitivity indices are obtained as the ratio of partial variance to the total output variance,
The number of sensitivity indices in (7) grow exponentially with k and typically only sensitivity indices of up to order two (S1 i and S2 i ) and the total-effect indices (ST i ) are estimated [28] . The total-effect index
measures the impact of main effect of X i and all its higher-order interaction effects with the other parameters [29] . The 130
Python SALib package was employed to perform the variance-based sensitivity analysis [27] . The calculations of S1 i , ST i 131 and S2 ij require n × (2k + 2) model evaluations using Saltelli's sampling scheme [30] where n is the sample size and k is 132 the number of input parameters. In this study, we considered n = 1000 unless otherwise specified, resulting in 18000 and 133 sample set with size n is categorized into the "Behavioral" subset (X i |EAD−) and the "Non-behavioral" (X i |EAD+) 141 with sizes n 1 and n 2 = n − n 1 , respectively, based on the absence and presence of EADs in simulated output. Empirical 142 cumulative density functions (CDF) F n1 (X i |EAD−) and F n2 (X i |EAD+) are estimated for both the subsets of random 143 input samples. The distance between the two empirical CDFs provides an estimate of sensitivity EAD feature to the 144 input parameter X i . Kolmogorov-Smirnov two-sample statistic test was used to quantify the difference between the two 145
CDFs. Kolmogorov-Smirnov test is characterized by a D-statistic and a p-value. The D-statistic is defined as [24] 146
The larger the D-statistic (or equivalently the smaller the p-value), the more important the input parameter is in driving 147
the behavior of the model to EAD [24] .
148
Binary risk stratification of virtual drug population 149 Logistic regression classifiers were constructed with both the direct, Table 2 , and derived features, Table 3 , individually or 150 in combinations as inputs for binary classification of the virtual population of drugs into EAD+ and EAD− categories. 151
To determine the targets for risk discrimination, the virtual population of drugs (n = 22000) generated for Sobol 
where M i represents the i th input metric to the model (which could be either a direct or a derived feature), n is the 158 number of input features used to train/test the model, and β i (i = 1, 2, ..n) are parameters to be determined. The 159 performance of the classifier was evaluated by K-fold cross validation and was reported in terms of Area Under the 160 Receiver Operating Characteristic Curve (AUC ROC) and Jaccard index (ratio of correctly classified samples to the total 161 number of samples). Python's scikit-learn package [31] was used to train/test the logistic-regression classifiers.
162
Tertiary risk stratification of "CiPA drugs"
163
In silico simulations of blocks with the 28 "CiPA drugs" were carried out using the in vivo manual patch clamp 164 measurements collected on the pharmacological effects of these compounds reported in [10, 12] were also classified by metrics constructed from the linear combination of input metrics with random coefficients β i as 171 described by
where F i represents the i th direct feature normalized by their ranges in the merged CiPA training and validation set, n is 173 the total number of direct features, and β i (i = 1, 2, ..., n) are coefficients of the i th feature. Several such linear metrics, 174 M l , were obtained by selecting sets of coefficients β i via Latin hypercube sampling. The Python SALib package was used 175
for Latin Hypercube sampling [27] .
176
The generalized classifier model equation is EFTPC values are highly variable [32] . In addition, the actual free plasma concentrations of drugs in subjects could also 193 differ because of inter-individual variations, impaired metabolism, and interactions with other drugs. In fact, drug 194 concentrations could potentially be much larger than reported maximum EFTPC values. We have recently proposed a 195 strategy [14] to partially resolve the problem of EFTPC variability by examining the drug-induced effects at 196 concentrations that result in identical block of hERG channel current for each drug. Therefore, in this study, in addition 197 to classification by EAD risk due to drug-induced changes in all seven ion-channel currents typically measured in in vitro 198 assays, we also examine the EAD model-derived metric that were constructed considering concentrations at a fixed value 199 sbIKr = 4. Also the parameter BCL was fixed to 1000. Table 3 . The circle size for the input parameters correspond to their relative importance, with the largest diameter circle denoting the most influential input and the smallest diameter circle denoting the least influential inputs.
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Variance-based analysis to be most sensitive to bIN aL, sbIKr, bIN a, and bICaL with contributions to the output variation of 30%, 26%, 17%, 227 and 10%, respectively. bICaL had the strongest impact on the variability of peakCa concentrations with an S1 index of 228 around 0.6. The difference between the ST and S1 indices in Figure 2B shows the impact of higher-order indices. Small 229 differences between S1 and ST for several derived metrics such as AP D90, qN et, peakCa suggest minor influence of 230 parameter interactions. The S1 and ST sensitivity indices obtained for all the derived features (Table 3 ) across different 231 cell types are reported in the Supplemental Material.
232
The Figure 3 shows a plot of the ST index against the µ * statistic from the Morris method. The observed strong 233 correlation is in agreement with previous analyses comparing elementary effects and variance-based methods [33] . Given 234 the results, the Morris method was able to rank the relative influence of parameters with similar accuracy of the more 235 computationally expensive variance-based method. However, as discussed earlier, the variance-based sensitivity measures 236 provide also additional information on parameter interactions. 237 
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Derived features predicted as linear combination of direct features 238 The estimated sum, S1 i , of the first-order Sobol indices S1 i for the i direct features (Table 2 ) for different 239 model-derived metrics are listed in Table 4 . S1 i represents the contribution of all individual input parameters, i.e., the 240 main effects, to the total variation of an output metric of the model without accounting for the influence of parameter 241 interactions. The observed values (Table 4) for CaT D50 feature (∼ 47% variance can be attributed to interactions). Note that although S1 does not account for the 246 effects of eventual interactions between parameters, contributions to the output variance from higher-order nonlinear 247 effects of individual inputs are indeed captured. For example, let us consider the simple model Y = x 1 + x 2 2 , for which 248 100% of the output variance is captured by the sum S1 x1 + S1 x2 . The S1 x2 index comprises an estimate of the variance 249
in Y due to the second-order term x 2 2 . Hence, even in the absence of parameter interactions, the model-derived metrics 250 can be nonlinear with respect to some inputs. We further examined the fitting of linear regressions of direct features 251 (assuming absence of nonlinearity and parameter interactions) to approximate the different model-derived metrics. The 252 goodness of fit was reported as R 2 values ( as linear combinations of the inputs, i.e., of the direct features. Moreover, the small differences between the S1 i and 256 the R 2 indicate minor contributions of higher-order terms of individual inputs on variation of most of the derived features 257 except for diastolicCa and peakV m. We also report the S1 i metric and R 2 values obtained for the M cell model in 258 Regional sensitivity analysis Figure 5A , B, C. The performance 288 measure of the classifiers reported as confusion matrices in Figure 5D , Randomly generated linear metrics 292
In the previous sections, we demonstrated that popular derived metrics for classification (i.e., AP D90, qN et) could be 293 well recapitulated by linear regressions constructed on direct features. In this section, we further explore the matter by 294 tackling the following question: What are the odds that a randomly generated metric based on the linear combination of 295 direct features would perform well in classification of TdP risk?
296
To address the problem, we automatically generated several classification metrics for the CiPA datasets as linear 297 combinations of the 5 normalized direct features sbIKr, bIN aL, bIN a, bICaL, and V half . Note that the parameters for 298
IKs, IK1, and Ito channels were not accounted for developing the metric as most of the CiPA compounds had minor 299 effects on these channels.
In the first step of our analysis, two groups of 40,000 sets of coefficients β i , i = 1, ..., 5 were randomly extracted via Latin 301
Hypercube Sampling (LHS) from within the prescribed bounds reported in the Table 6 . The first group of coefficient sets 302 (group A) was selected to ensure a certain degree of correlation to AP D, as exhibited by many derived metrics. More categories. In other words, the probability that a randomly generated metric would perform as well as qN et, which also 310 achieves perfect accuracy, is quite low. Figure 6A shows frequency of the drugs that are correctly classified by metrics 311 generated from the coefficient sets of group A. We observe that a classifier built on a metric with random coefficients The low probability of having randomly generated metrics that would perform at least as well as AP D90 and qN et 315 highlights the strong link between perturbed AP D in an isolated cell and TdP risk.
316
The second step of the analysis targeted the small portion of metrics that were able to classify correctly at least 11 out 317 of the 12 drugs of the training set. The selected metrics were further tested for classifying the merged training-validation 318 set from CiPA, again via multiclass logistic regression. Note that we refit logistic regression (12) to the merged dataset 319 instead of reusing coefficients γ i obtained for the training set to quantify the ability of the metrics to separate full set of 320 drugs into correct categories. Figure 6B and C show the frequencies of correctly predicted drugs from the merged 321 training-validation dataset, but when accounting only for the selected metrics generated from group A that were able to 322 classify correctly at least 11 of the 12 training drugs. Note that the peakCa and AP D90 based metrics classified correctly 323 less than 11 training drugs, but were included in these subpanels just for comparision. 0  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28 No. correct classified drugs Table 6 . A: Frequency distribution of the randomly generated metrics that classify a given number of CiPA training drugs correctly. B: Frequency distribution of the subset of randomly generated metrics that classify a given number of CiPA training and validation drugs correctly and all of the CiPA training drugs. C: Frequency distribution of the subset of randomly generated metrics that classify a given number of CiPA training and validation drugs correctly and at least 11 of the 12 CiPA training drugs. Labels qN et, AP D90, and peakCa point to accuracy of these metrics for comparison. In order to estimate the confidence intervals, LHS was repeated for 100 different random seeds. changes of these two parameters were taken into consideration. We also compared the obtained thresholds for EADs to 334 the thresholds considering drug-induced changes of all the seven ion channel currents measured from the in vitro assays 335 and characterized by the 9 parameters reported in Table 2 . The results are summarized in the Table 7 . Our EAD analysis 336
show that the drugs in the high-risk category had consistently a threshold value of less than 7, even for the threshold 
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Logistic regression classifiers for EAD risk 355 Feature ranking was implemented using an approach similar to [9] . Figure 7 shows the clustering map obtained using 368 unsupervised hierarchical clustering on the correlation coefficient matrix of the features. The feature with the best ROC 369 AUC when tested individually was ranked the highest (rank=1). Subsequent features were chosen with the next best 370 ROC AUC score but were conditioned to being picked from outside of the cluster of the previously chosen features. Once 371 a feature from each cluster was picked, the remaining features were ranked based on their ROC AUC scores. The 372 obtained feature ranks are listed in map of direct features, each feature appears in a separate group (Figure 7 A) . The cluster number is the same as the 375 feature rank when only the direct features are considered, and hence were not reported in the Table 8 . 376 
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Discussion 377
Here we presented a study that applied GSA within the context of in silico prediction of pharmacological toxicity. The 378 target of GSA is the latest version of the in silico model of an isolated cardiac cell [11] , CiPAORd, which was developed 379 under the CiPA initiative and incorporates dynamic hERG-drug interactions [10] . Our analysis explored the effects of a 380 large population of virtual drugs on the seven major cardiac ion-channel currents thought to be important in regulation of 381
TdP. GSA provided a systematic understanding of the model input/output relationships and allowed for the identification 382 of the most influential parameters that regulate model-derived features of interest. In the future, the knowledge gained 383 from GSA could help improve the model structure and potentially guide the design of novel effective experiments to 384 increase reliability of model-driven predicted risk.
385
GSA of AP D 90 , qN et, peakCa, and EADs 386 Different methods and tools, each with their own advantages and disadvantages, allow for the analysis of the sensitivity of 387 complex model systems to the input parameters (e.g, refer to [24, 28, 34] for thorough reviews on the subject). Unlike we used two GSA methods, the difference-based Morris sensitivity method [23] , and the Sobol's variance-based sensitivity 391 method [24, 25] , to rank cardiac ion-channel currents based on their relative contributions to output variability in the 392 model. We also performed regional sensitivity analysis [24, 26] to determine the cardiac ion-channels responsible for 393 regulation of the EAD generation in the CiPAORd models. in sodium currents and to the sbIKr parameter. sbIKr is the most influential parameter regulating AP D90. In spite of 398 these observed dissimilarities, different derived metrics have been reported to perform well on particular in vitro drug 399 effects datasets. AP D90 [6] , a metric based on AP D50 and diastolicCa [9] , and a metric based on EADs [7] , have been 400 shown to provide good risk discrimination of drugs considering in vitro measurements reported in [6] . We have shown 401 previously that different derived features extracted from the original ORd model [19] show similar performance in TdP 402 risk discrimination [14] when tested on a combination of several datasets. The similarity in performance of different 403 metrics might be due to the presence of estimates of drug effects on only three channel currents (i.e., fast sodium current, 404 L-type calcium channel current, and hERG current) in the majority of the datasets, the small size of the datasets, and 405 the differences in structure of the myocyte models used for obtaining the derived feature. Different derived metrics, such 406
as AP D50, AP D90, peakCa, and CaD90 have been shown to provide the best classification when varying the 407 computational model of interest [6] .
408
It should be noted that GSA results are highly dependent on explored parametric space. Here, we evaluate the that accurate classification of the Ranolazine drug to low risk category requires a feature that is at least moderately 417 sensitive to variations in block of late sodium current, since the drug appears to be a pure hERG and sodium channel 418 blocker. Our GSA results (Figures 1 and 2 Drug-induced block of non-hERG ion channels for 28 CiPA compounds at their EFTPC based on the measurements from the in vitro assay [12, 35] . A: Stacked bar chart of six ion channel current block values for each of the 28 drugs.B: A swarm plot of block values of six ion channel currents categorized into high, medium, and low risk groups.
421
The results of our Monte Carlo filtering analysis ( Table 5 and Figure 4 ) indicate that the generation of EADs, which 422 are thought to be cellular precursors of TdP genesis [20] , are most sensitive to variations in block of ICaL and to the Figure 4 ). Our analysis shows that several of the derived features proposed previously are 426 sensitive to different model inputs than those for EADs (see Figure 1 ). For example, the qN et metric is sensitive to 427 variations in block of sodium currents and block of sbIKr for the endo cell model. In contrast, the bICaL and sbIKr 428 parameters are the most influential for regulating EADs.
429 Surprisingly, the recently introduced dynamic-hERG block parameters V half and Ku [10] , which are measured using 430 challenging experimental protocols [36, 37] , show minor influence on EAD genesis (Table 5 ) when compared to other 431 tested inputs. These parameters have relatively small contribution to the variance of all the tested derived metrics 432 compared to other influential input parameters (Figure 1, 2 , and data in the Supplemental Material). In cases where the 433 majority of the primary regulating parameters are similar between drugs, accounting for changes in the modestly 434 influential parameters can allow for improved predictions. We observe that a surrogate of qN et estimated by inclusion of 435 the V half parameter allows for improved prediction of few intermediate risk drugs (Figure 5) . Similarly, when classifying 436
CiPA drugs based on EADs, we observe that prediction improves by correctly classifying 3 more drugs when accounting 437 for drug-induced effects of other parameters in addition to the sbIKr and bICaL parameters (Table 7) . However, our 438 results also point towards the important consideration that errors in measuring the most influential parameters regulating 439 a particular metric have a bigger impact on the predicted classification compared to neglecting some of the less influential 440 parameters. GSA allows us to determine and rank most of the critcal model components. Uncertainties in in vitro measurements of drug-induced effects on ionic currents present an important concern in 443 evaluating the torsadogenic risk of compounds by interrogating in silico biophysical models. Discrepancies in estimates 444 for model parameters based on available in vitro assay data have been recently highlighted in uncertainty quantification 445 studies [38, 39] . High uncertainty in model parameters leads to low confidence in model predicted risk, and thus, not 446 surprisingly, risk stratification of the CiPA training drugs proved to be unreliable especially at high drug 447
concentrations [39] , where model parameter estimates are inherently less accurate. However, it is important to emphasize 448 that the relative contributions of drug-induced modulation of ion-channels on output features differ significantly.
449
Uncertainties in model input parameters that are higly influential (e.g., as revealed by GSA) result, therefore, in lower 450 confidence in the predicted risk, while errors in estimating less influential model parameters are better tolerated by risk 451
measures [40] .
452

GSA vs. linear regression 453
The link between GSA and feature selection is well illustrated in the following example. We consider that some 
where {x i } is a vector of direct features; {a i } and {b ij } are a vector and a symmetric matrix of coefficients for the linear 457 and quadratic terms of the poylnomial, respectively, and c is a constant. The components of {x i }, i.e., the individual 458 direct features, are assumed to be uniformly distributed with expectation e i and variance v i . In this case, the effect of 459 each direct feature x i and the joint effect of direct features x i x j on variance in M are given by
Typically, to rank the features based on their importance, feature scaling is carried out on the inputs before performing the regression. If each of the uniformly distributed direct features x i are centered and normalized to have e i = 0 and v i = 1, then
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Hence, the first-and second-order Sobol indices can be represented as
Expressions in (19)- (20) provide a link between calculated variances in the Sobol sensitivity method and the coefficients 461 of the polynomial. Indeed, to demonstrate these relationships, we fitted a linear regression to approximate model-derived 462 metrics (AP D90, qN et, and peakCa) accounting for only the first-order effects of the direct features, i.e., 463 M = c + a i x i . Then, the squared coefficients of the regression are normalized by the variance of derived features and 464 compared with Sobol S1 index. As expected, in the presence of minor interactions and nonlinear effects for these derived 465 metrics ( Table 4) , we observe a good match between indices estimated from the regression coefficients and the Sobol S1 466 indices as shown in Figure 9 , even when considering only the first-order effects to construct the regression.
467
Linear Regression S1 performance as candidate metrics for risk classification depending on the training datset [6-11, 17, 18] . However, while 473 biophysical models provide a mechanistic understanding, the equivalent predictive capability of direct features that do not 474 require modeling have raised concerns on whether the added complexity introduced by modeling is in fact necessary for 475 risk classification purposes [15] . We have recently shown comparable accuracies for TdP risk classification from direct 476 features in tests against several of the other published methods [14] . Few previous studies [13, 15, 16] have also reported 477 similar findings for particular datasets where metrics based on direct features provided high predictive power. probability to obtain one that performs as well as qN et. However, the probability that a randomly generated metric 493 would also perform satisfactorily on the 28-drug merged dataset from the CiPA initiative is very low, with only 0.2% of 494 the tested metrics being able to classify correctly more than 23 compounds. Our overall analysis thus supports qN et as a 495 metric for TdP risk classification. into a group of EAD generating drugs and a group of drugs that do not produce EADs (Table 8 ). This is in agreement 500 with our GSA results, with none of the tested derived features demonstrating identical sensitivity profile to EAD (Figure 501 1, 2 and the Supplemental material). qN et has been shown to provide excellent classification of drugs in the CiPA 502 training and validation data, a result thought to be linked to EAD generation [11, 12] . However, we observe that the 503 categorization of CiPA drugs based on analysis of EADs was not as predictive (Table 7) as model-derived metric such as 504 qN et ( Figure 5 ). Our GSA indicates that qN et and EAD do not fully share sensitivity profiles (Figure 1, 2) . Hence, the 505 previously reported correlation between qN et and EAD generation [11] seems to be not justified. The proarrhythmic risk assessment based on simulated drug responses in isolated cell model [6] [7] [8] [9] [10] [11] [12] 18] , tissue 514 models [41, 42] or organ level computational models [17, 43] can provide physiological/mechanistic insights and 515 interpretability. Moreover, in silico models serve as an excellent tool for evaluation of drug safety in diseased 516 conditions [41, 42] . Surprisingly, the present analysis reveals, however, that several of currently proposed model-derived 517 metrics for TdP risk classification can be well captured as linear combination of the set of direct features. The analysis 518 also highlights the key differences in the most influential cardiac ion-channels affecting the different model-derived metrics 519 28/48 and pointing towards a need for better mechanistic understanding of a promising metric such as qN et. from [12] . The values are reported in Table 9 . hERG dynamic data was extracted from [10] and [12] for the training and validation compounds, respectively, as listed 530
529
in Table 10 . In the simulations, the reported median values of parameters were used. The known TdP categories and maximum effective free therapeutic concentrations for the validation drugs ( [10, 12] ) 532 are listed in Table 11 . The figures (Figure 10, 11, 12) show values of the derived features extracted from the simulation of virtual drugs 536 generated for the Sobol sensitivity analysis against individual input parameters. TdP risk classification of "CiPA drugs" based on transmural dispersion of repolarization 550
The "CiPA drugs" were also calssified based on the transmural dispersion of repolarizations as shown in Figure 19 . , as in our previous study [14] . Uniformly spaced samples in this 3D 555 space were selected to generate a set of virtual drugs. The virtual drugs were simulated and outputs of the in silico 556 models were visualized for presence or absence of EADs (Figure 20) . The region in green in the Figure 20 denotes the 557 region of the examined parameteric space where EADs were not observed in the CiPAOrd model, while the region in red 558 denotes the region with presence of EADs in the model. The surface separating the EAD+ and EAD− regions is shown 559
in yellow for the CiPAORd model [10] . For comparision the estimated surface separating the EAD+ and EAD− for the 560 original ORd model is shown in blue. [19] . The CiPA training compounds were plotted as red (High risk drugs), yellow 561 (Intermediate risk drugs) and green (Low risk drugs) dots. 
